Expands Reach Beyond Current Partnerships and Integration Agreements
The new module expands the connectivity and integration capabilities beyond the current Practice Management Systems and enables compatibility with all systems. This additional compatibility broadens the potential customer base and increases the addressable market for the Company’s fast-growing iCoreVerify software.
Among the module’s unique features is its Adaptive Import Mechanism, a user-friendly tool that streamlines workflows and increases efficiencies by allowing users to save templates of recurring imports. The module also brings users enhanced workflow speed through automation with its intelligent duplicate detection system and update mechanism.
About
Forward-Looking Statements
Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the Company’s revenue and annualized recurring revenue estimates for 2023, the Company’s ability to grow opportunities within ePrescription and insurance verification, and the Company's ability to continue to expand its reach into medical customers. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. The Company has attempted to identify forward-looking statements by terminology including ‘believes,’ ‘estimates,’ ‘anticipates,’ ‘expects,’ ‘plans,’ ‘projects,’ ‘intends,’ ‘potential,’ ‘may,’ ‘could,’ ‘might,’ ‘will,’ ‘should,’ ‘approximately’ or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. “Risk Factors” in the Company’s most recently filed Form 10-K filed with the
Investor Contacts:
312-445-2870
ICCT@alpha-ir.com
Source:
2023 GlobeNewswire, Inc., source